As a doctor specializing in bone marrow transplantation, I enjoy forming long-term relationships with patients and their families and traveling with them on their journey.
Everyone’s path is different, and our team of doctors and nurses is committed to exceptional care. We deliver personalized treatments to each child and adolescent — one size fits no one!
I am honored to be president-elect of the American Society of Transplantation and Cellular Therapy, the professional society for bone marrow transplant specialists.
In my research, my colleagues and I focus on finding out what causes complications after bone marrow transplantation and determine better ways to fix these complications.
In my spare time, I enjoy supporting my daughter, a Cincinnati Rollergirl, at roller derby bouts.
MBBS: University of Newcastle-Upon-Tyne, England, 1981.
Clinical and Fellowship Training: The Royal Victoria Infirmary, Newcastle General Hospital and Great Ormond St. Hospital, 1981 to 1985.
PhD: University of Newcastle-Upon-Tyne, England, 1989.
Pediatric Fellowship: University of Minnesota, Minneapolis, MN, 1989 to 1993.
Bone Marrow Transplantation BMT, Fanconi Anemia, Leukemia, Sarcoma, Cancer and Blood Diseases, Rare Lung Diseases
Bone Marrow Transplantation and Immune Deficiency, Cancer and Blood Diseases
Cincinnati Children's strives to accept a wide variety of health plans. Please contact your health insurance carrier to verify coverage for your specific benefit plan.
Childhood cancer etiology: recent reports. Pediatric Blood and Cancer. 2003; 40:35-38.
Is it possible to catch leukaemia from a cat?. The Lancet. 1994; 344.
Epidemiology of childhood leukemia, with a focus on infants. Epidemiologic Reviews. 1994; 16:243-272.
Maintenance of genomic imprinting at the IGF2 locus in hepatoblastoma. Cancer Research. 1993; 53:4781-4783.
Bone marrow transplant for acute leukaemia. Best Practice and Research in Clinical Haematology. 1991; 4:483-510.
Gonadal function in pediatric Fanconi anemia patients treated with hematopoietic stem cell transplant. Haematologica. 2023.
The Choice of Either Conventional Chemotherapy or Inotuzumab Ozogamicin as Bridging Regimen Does Not Appear To Impact Clinical Response to CD19-Directed CAR-T Therapy in Pediatric B-ALL. Transplantation and cellular therapy. 2023.
Daytime-restricted parenteral feeding is associated with earlier oral intake in children following stem cell transplant. Journal of Clinical Investigation. 2023; 133.
Transcriptome analysis in acute gastrointestinal graft-versus host disease reveals a unique signature in children and shared biology with pediatric inflammatory bowel disease. Haematologica. 2023.
Reduced-Intensity Conditioning Mitigates Risk for Primary Ovarian Insufficiency but Does Not Decrease Risk for Infertility in Pediatric and Young Adult Survivors of Hematopoietic Stem Cell Transplantation. Transplantation and cellular therapy. 2023; 29:130.e1-130.e8.
Patient Ratings and Comments
All patient satisfaction ratings and comments are submitted by actual patients and verified by a leading independent patient satisfaction company, NRC Health. Patient identities are withheld to ensure confidentiality and privacy. Only those providers whose satisfaction surveys are administered through Cincinnati Children’s Hospital Medical Center are displayed. Click here to learn more about our survey